de novo mutations congenital heart disease neurodevelopmental congenital anomalies 
congenital heart disease chd patients increased prevalence extracardiac congenital anomalies cas risk neurodevelopmental disabilities ndds exome sequencing chd parent-offspring trios identified excess protein-damaging de novo mutations especially genes highly expressed developing heart brain mutations accounted % patients chd ndd ca % patients isolated chd mutations altered genes involved morphogenesis chromatin modification transcriptional regulation including multiple mutations rbfox2 regulator mrna splicing genes mutated cohorts examined ndd enriched chd cases particularly coexisting ndd findings reveal shared genetic contributions chd ndd ca provide opportunities improved prognostic assessment early therapeutic intervention chd patients 
